ArticleBreast cancer research and treatment2010

The Leu33Pro polymorphism in the ITGB3 gene does not modify BRCA1/2-associated breast or ovarian cancer risks: results from a multicenter study among 15,542 BRCA1 and BRCA2 mutation carriers.

Anna Jakubowska et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.